Search

Your search keyword '"Scagliotti, Giorgio"' showing total 239 results

Search Constraints

Start Over You searched for: Author "Scagliotti, Giorgio" Remove constraint Author: "Scagliotti, Giorgio" Journal journal of thoracic oncology Remove constraint Journal: journal of thoracic oncology
239 results on '"Scagliotti, Giorgio"'

Search Results

1. Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA)

2. The International Association for the Study of Lung Cancer Early Lung Imaging Confederation Open-Source Deep Learning and Quantitative Measurement Initiative

5. The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015

6. Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer

7. The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer

8. Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic

9. Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations

10. IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

11. New Approaches to SCLC Therapy: From the Laboratory to the Clinic

13. A Randomized-Controlled Phase 2 Study of the MET Antibody Emibetuzumab in Combination with Erlotinib as First-Line Treatment for EGFR Mutation–Positive NSCLC Patients

14. Definition of Synchronous Oligometastatic Non–Small Cell Lung Cancer—A Consensus Report

15. Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma

16. Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer

17. Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC

19. The IASLC Early Lung Imaging Confederation (ELIC) Open-Source Deep Learning and Quantitative Measurement Initiative

20. Multicenter Comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) Assays to Test PD-L1 Expression for NSCLC Patients to Be Treated with Immune Checkpoint Inhibitors

21. Scientific Advances in Thoracic Oncology 2016

23. Scientific Advances in Lung Cancer 2015

30. An Open-Label, Multicenter, Randomized, Phase II Study of Pazopanib in Combination with Pemetrexed in First-Line Treatment of Patients with Advanced-Stage Non–Small-Cell Lung Cancer

32. An Open-Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC-A12) as a First-Line Therapy in Patients With Advanced Nonsquamous Non–Small Cell Lung Cancer

33. Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid: Subgroup Analysis from a Randomized Phase 3 Study

36. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

44. Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA)

Catalog

Books, media, physical & digital resources